Generic Policy Tweaks In Omnibus Legislation Include Processes Improvements On Late-Stage Label Changes, 505(b)(2) TE Designations

 
• By M. Nielsen Hobbs
Red and Blue Pills
• Source: Shutterstock

More from Generics

More from Biosimilars & Generics